-
Mashup Score: 8
MSK Continuing Medical Education, Celebrating 25 Years of Innovation in Integrative Oncology: Recent Advances and Future Opportunities, 5/17/2024 8:00:00 AM – 5/17/2024 6:00:00 PM, Join leading experts for a one-day conference exploring evidence-based, patient-centered care advancements in integrative medicine. Our expert speakers will guide participants through effective methods for managing symptoms and side effects associated with cancer treatment, such as pain, anxiety, and fatigue, using integrative strategies including exercise, nutrition, acupuncture, massage, meditation, yoga, and music therapy. Through a series of engaging lectures and panel discussions, we’ll also discuss how to build meaningful collaborations to increase equitable access to these therapies along the patient care journey. This symposium serves as a platform for fostering a comprehensive understanding of integrative medicine, highlighting current achievements, and identifying avenues for growth in delivering h
Source: mskcc.cloud-cme.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3HemeTalks: Conversations in Hematology Education: Multiple Myeloma in Underrepresented Populations: Treatment Considerations on Apple Podcasts - 3 month(s) ago
Show HemeTalks: Conversations in Hematology Education, Ep Multiple Myeloma in Underrepresented Populations: Treatment Considerations – Jan 31, 2024
Source: podcasts.apple.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1HemeTalks: Conversations in Hematology Education: Multiple Myeloma in Underrepresented Populations: Survival Outcomes on Apple Podcasts - 3 month(s) ago
Show HemeTalks: Conversations in Hematology Education, Ep Multiple Myeloma in Underrepresented Populations: Survival Outcomes – Jan 31, 2024
Source: podcasts.apple.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5
Leukemia – Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
The decision to test for MGUS was not made based on clinical decisions. MGUS prevalence in asymptomatic individuals was determined and published previously by @DrOlaLandgren and @VincentRK in the 2 papers cited https://t.co/cNTPmahQJr https://t.co/zRs2zZKz3g @JanineMJoseph #mmsm https://t.co/drY3MdKSyf https://t.co/EZDigj1NFN
-
-
Mashup Score: 15
A new study confirms that adhering to the AICR Cancer Prevention Recommendations reduces the risk of breast, colorectal and lung cancers.
Source: www.aicr.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Unraveling the diversity and functions of tissue-resident plasma cells - Nature Immunology - 3 month(s) ago
Terminally differentiated plasma cells reside in multiple tissues to contribute to local immunity. Nutt and colleagues examined tissue-specific differences in long-lived plasma cell lifespan and function, identifying unique transcriptional attributes in addition to the core plasma cell program.
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 23Body size and risk of multiple myeloma in the Black Women’s Health Study - British Journal of Cancer - 4 month(s) ago
Obesity is an established risk factor for multiple myeloma (MM). Relatively few prior studies, however, have evaluated associations in Black populations. Among 55,276 participants in the Black Women’s Health Study, a prospective U.S. cohort established in 1995, we confirmed 292 incident diagnoses of MM over 26 years of follow-up. Multivariable Cox proportional hazard models, adjusted for age and…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3COVID-19 and Diet: Does what you eat matter? - 4 month(s) ago
Professor Tim Spector is joined by Dr Sarah Berry and Emily Leeming RD from Kings College London and Professor Andrew Chan from Harvard to discuss our latest…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Reducing Adverse Effects of Proton Pump Inhibitors - 4 month(s) ago
Proton pump inhibitors effectively treat gastroesophageal reflux disease, erosive esophagitis, duodenal ulcers, and pathologic hypersecretory conditions. Proton pump inhibitors cause few adverse effects with short-term use; however, long-term use has been scrutinized for appropriateness, drug-drug interactions, and the potential for adverse effects (e.g., hip fractures, cardiac events, iron deficiency, Clostridium difficile infection, pneumonia). Adults 65 years and older are more vulnerable to these adverse effects because of the higher prevalence of chronic diseases in this population. Proton pump inhibitors administered for stress ulcer prophylaxis should be discontinued after the patient is discharged from the intensive care unit unless other indications exist.
Source: www.aafp.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5
Program: Oral and Poster Abstracts Session: 654. MGUS, Amyloidosis and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster III Hematology Disease Topics & Pathways: clinical trials, adult, Research, Clinical Research, Plasma Cell Disorders, Diversity, Equity, and Inclusion (DEI) , Diseases, immune mechanism, patient-reported outcomes, Lymphoid Malignancies, metabolism, Biological Processes, microbiome, Metabolic Disorders, Human, Study Population Urvi A Shah, MD 1, Francesca
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet
Excited to be a part of this one-day (May 17) conference focused on patient-centered integrative medicine advances in exercise, nutrition, acupuncture, massage, meditation, yoga, & music therapy in cancer! Registration/details: https://t.co/iwb5RJfO9M #MSKIntegrativeOncCME https://t.co/0h2r257jQg https://t.co/euysxziVp6